5-hydroxytryptophan has been researched along with Astrocytosis in 1 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borroni, E | 1 |
| Bohrmann, B | 1 |
| Grueninger, F | 1 |
| Prinssen, E | 1 |
| Nave, S | 1 |
| Loetscher, H | 1 |
| Chinta, SJ | 1 |
| Rajagopalan, S | 1 |
| Rane, A | 1 |
| Siddiqui, A | 1 |
| Ellenbroek, B | 1 |
| Messer, J | 1 |
| Pähler, A | 1 |
| Andersen, JK | 1 |
| Wyler, R | 1 |
| Cesura, AM | 1 |
1 other study available for 5-hydroxytryptophan and Astrocytosis
| Article | Year |
|---|---|
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.
Topics: 5-Hydroxytryptophan; Acetamides; Alzheimer Disease; Animals; Astrocytes; Gliosis; Humans; Hypertensi | 2017 |